SOTERA HEALTH COMPANY Capital Expenditures Incurred but Not yet Paid
SOTERA HEALTH COMPANY (SHC) reported Capital Expenditures Incurred but Not yet Paid of $35.40 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:CapitalExpendituresIncurredButNotYetPaid · last filed 2026-08-06
- SOTERA HEALTH COMPANY capital expenditures incurred but not yet paid for the quarter ending 2026-06-30 was $14.71M.
- SOTERA HEALTH COMPANY capital expenditures incurred but not yet paid for the quarter ending 2026-03-31 was $20.69M, a 58.63% increase year-over-year.
- SOTERA HEALTH COMPANY capital expenditures incurred but not yet paid for the quarter ending 2025-12-31 was $8.12M.
- SOTERA HEALTH COMPANY capital expenditures incurred but not yet paid for the quarter ending 2025-09-30 was $6.91M, a 143.75% increase year-over-year.
- SOTERA HEALTH COMPANY capital expenditures incurred but not yet paid for fiscal 2025 was $25.33M, a 148.82% increase from fiscal 2024.
- SOTERA HEALTH COMPANY capital expenditures incurred but not yet paid for fiscal 2024 was $10.18M, a 39.11% decline from fiscal 2023.
- SOTERA HEALTH COMPANY capital expenditures incurred but not yet paid for fiscal 2023 was $16.72M, a 1.87% increase from fiscal 2022.
- SOTERA HEALTH COMPANY capital expenditures incurred but not yet paid for fiscal 2022 was $16.41M, a 13.01% increase from fiscal 2021.
| Period end | Capital Expenditures Incurred but Not yet Paid 3 month | Capital Expenditures Incurred but Not yet Paid 6 month | Capital Expenditures Incurred but Not yet Paid 9 month | Capital Expenditures Incurred but Not yet Paid 12 month |
|---|---|---|---|---|
| 2026-06-30 | $14.71M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $35.40M 10-Q · filed 2026-08-06 | $43.51M derived: sum of 3 quarters · filed 2026-08-06 | $50.42M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $20.69M 10-Q · filed 2026-05-05 | $28.80M derived: sum of 2 quarters · filed 2026-05-05 | $35.71M derived: sum of 3 quarters · filed 2026-05-05 | $32.98M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $8.12M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $15.02M derived: sum of 2 quarters · filed 2026-02-24 | $12.29M derived: sum of 3 quarters · filed 2026-08-06 | $25.33M 10-K · filed 2026-02-24 |
| 2025-09-30 | $6.91M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $4.17M derived: sum of 2 quarters · filed 2026-08-06 | $17.21M 10-Q · filed 2025-11-04 | $11.02M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$2.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $10.31M 10-Q · filed 2026-08-06 | $4.12M derived: sum of 3 quarters · filed 2026-08-06 | $6.95M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $13.04M 10-Q · filed 2026-05-05 | $6.85M derived: sum of 2 quarters · filed 2026-05-05 | $9.68M derived: sum of 3 quarters · filed 2026-05-05 | $7.77M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | -$6.19M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$3.36M derived: sum of 2 quarters · filed 2026-02-24 | -$5.27M derived: sum of 3 quarters · filed 2026-02-24 | $10.18M 10-K · filed 2026-02-24 |
| 2024-09-30 | $2.83M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $918.00K derived: sum of 2 quarters · filed 2025-11-04 | $16.37M 10-Q · filed 2025-11-04 | $16.71M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-06-30 | -$1.92M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $13.54M 10-Q · filed 2025-08-08 | $13.88M derived: sum of 3 quarters · filed 2026-02-24 | $13.27M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-03-31 | $15.45M 10-Q · filed 2025-05-01 | $15.79M derived: sum of 2 quarters · filed 2026-02-24 | $15.19M derived: sum of 3 quarters · filed 2026-02-24 | $19.11M derived: sum of 4 quarters · filed 2026-02-24 |
| 2023-12-31 | $337.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$266.00K derived: sum of 2 quarters · filed 2026-02-24 | $3.66M derived: sum of 3 quarters · filed 2026-02-24 | $16.72M 10-K · filed 2026-02-24 |
| 2023-09-30 | -$603.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | $3.32M derived: sum of 2 quarters · filed 2024-11-05 | $16.38M 10-Q · filed 2024-11-05 | $14.21M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $3.92M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | $16.99M 10-Q · filed 2024-08-05 | $14.82M derived: sum of 3 quarters · filed 2025-02-27 | $15.48M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $13.06M 10-Q · filed 2024-05-02 | $10.89M derived: sum of 2 quarters · filed 2025-02-27 | $11.55M derived: sum of 3 quarters · filed 2025-02-27 | $19.97M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | -$2.17M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$1.51M derived: sum of 2 quarters · filed 2025-02-27 | $6.91M derived: sum of 3 quarters · filed 2025-02-27 | $16.41M 10-K · filed 2025-02-27 |
| 2022-09-30 | $660.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $9.07M derived: sum of 2 quarters · filed 2023-11-01 | $18.58M 10-Q · filed 2023-11-01 | $18.58M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | $8.41M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $17.92M 10-Q · filed 2023-08-03 | $17.92M derived: sum of 3 quarters · filed 2024-02-27 | $22.78M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | $9.51M 10-Q · filed 2023-05-03 | $9.51M derived: sum of 2 quarters · filed 2024-02-27 | $14.36M derived: sum of 3 quarters · filed 2024-02-27 | $16.64M derived: sum of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | -$3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $4.85M derived: sum of 2 quarters · filed 2024-02-27 | $7.13M derived: sum of 3 quarters · filed 2024-02-27 | $14.52M 10-K · filed 2024-02-27 |
| 2021-09-30 | $4.86M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $7.14M derived: sum of 2 quarters · filed 2022-11-02 | $14.53M 10-Q · filed 2022-11-02 | $20.32M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | $2.28M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $9.67M 10-Q · filed 2022-08-04 | $15.46M derived: sum of 3 quarters · filed 2023-02-28 | $16.82M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | $7.39M 10-Q · filed 2022-05-05 | $13.18M derived: sum of 2 quarters · filed 2023-02-28 | $14.54M derived: sum of 3 quarters · filed 2023-02-28 | $16.58M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | $5.79M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $7.15M derived: sum of 2 quarters · filed 2023-02-28 | $9.19M derived: sum of 3 quarters · filed 2023-02-28 | $14.29M 10-K · filed 2023-02-28 |
| 2020-09-30 | $1.35M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $3.39M derived: sum of 2 quarters · filed 2021-11-10 | $8.49M 10-Q · filed 2021-11-10 | |
| 2020-06-30 | $2.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $7.14M 10-Q · filed 2021-08-12 | ||
| 2020-03-31 | $5.10M 10-Q · filed 2021-05-13 | |||
| 2019-12-31 | $5.20M 10-K · filed 2022-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |